Free shipping on all orders over $ 500

ITMN 4077 

Cat. No. M55815

All AbMole products are for research use only, cannot be used for human consumption.

ITMN 4077  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

ITMN 4077 is a macrocyclic inhibitor against Hepatitis C Virus (HCV) NS3 protease (EC50: 2131 nM).

Chemical Information
Molecular Weight 568.68
Formula C26H40N4O8S
CAS Number 790305-05-4
Form Solid
Solubility (25°C) DMSO ≥ 100 mg/mL
Storage Powder -20°C
Related HCV Protease Products
Telaprevir

Telaprevir (VX-950) is a novel hepatitis C virus (HCV) NS3-4A protease inhibitor with IC50 of < 0.2 μM.

BMS-790052

BMS-790052 (Daclatasvir) is a first-in-class, nonstructural protein 5A (NS5A) replication complex inhibitor with an EC50 of 9-50 pM.

(R)-Nepicastat hydrochloride

(R)-Nepicastat hydrochloride, the R-enantiomer of Nepicastat hydrochloride, is a potent and selective inhibitor with IC50 of 25.1 nM and 18.3 nM for bovine and human dopamine-β-hydroxylase, with negligible affinity for twelve other enzymes and thirteen neurotransmitter receptors.

Elbasvir

Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) replication complex inhibitor, with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.

Dasabuvir (ABT-333)

ABT-333 is a nonnucleoside NS5B polymerase inhibitor for the treatment of HCV infection.

  Catalog
Abmole Inhibitor Catalog




Keywords: ITMN 4077  supplier, HCV Protease, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.